BACKGROUND: BRCA1-associated protein 1 (BAP1) represents a recently identified tumor suppressor protein. Loss of BAP1 has been observed in cutaneous epithelioid Spitz tumors. These cutaneous melanocytic tumors show a distinct histopathologic phenotype characterized by an intradermal sheet-like proliferation of epithelioid melanocytes. METHODS: We retrospectively reviewed the clinical outcomes, histopathologic findings and immunophenotype in spitzoid melanocytic neoplasms with the morphologic features seen in BAP1 mutated Spitz tumors. Cases were obtained from our files. BAP1 immunohistochemistry was evaluated dichotomously for the presence of nuclear staining. RESULTS: Fifteen of 19 cases showed loss of nuclear BAP1 expression. Of the 15 cases displaying nuclear loss of BAP1, clumped perinuclear staining was observed in 8 cases while 7 cases showed complete loss. Follow up ranging from 0-45 months (mean 17 months) was uneventful. CONCLUSIONS: Our data are consistent with an indolent overall clinical course for epithelioid Spitz tumors with loss of BAP1. Furthermore, a large subset of epithelioid Spitz tumors display loss of nuclear expression but show a reproducible clumped perinuclear staining pattern.
BACKGROUND:BRCA1-associated protein 1 (BAP1) represents a recently identified tumor suppressor protein. Loss of BAP1 has been observed in cutaneous epithelioid Spitz tumors. These cutaneous melanocytic tumors show a distinct histopathologic phenotype characterized by an intradermal sheet-like proliferation of epithelioid melanocytes. METHODS: We retrospectively reviewed the clinical outcomes, histopathologic findings and immunophenotype in spitzoid melanocytic neoplasms with the morphologic features seen in BAP1 mutated Spitz tumors. Cases were obtained from our files. BAP1 immunohistochemistry was evaluated dichotomously for the presence of nuclear staining. RESULTS: Fifteen of 19 cases showed loss of nuclear BAP1 expression. Of the 15 cases displaying nuclear loss of BAP1, clumped perinuclear staining was observed in 8 cases while 7 cases showed complete loss. Follow up ranging from 0-45 months (mean 17 months) was uneventful. CONCLUSIONS: Our data are consistent with an indolent overall clinical course for epithelioid Spitz tumors with loss of BAP1. Furthermore, a large subset of epithelioid Spitz tumors display loss of nuclear expression but show a reproducible clumped perinuclear staining pattern.
Authors: Gregory A Hosler; Teresa Davoli; Ilgen Mender; Brandon Litzner; Jaehyuk Choi; Payal Kapur; Jerry W Shay; Richard C Wang Journal: J Cutan Pathol Date: 2014-12-11 Impact factor: 1.587
Authors: Michele Donati; Petr Martinek; Petr Steiner; Petr Grossmann; Tomas Vanecek; Liubov Kastnerova; Isabel Kolm; Martina Baneckova; Pietro Donati; Irina Kletskaya; Antonina Kalmykova; Josef Feit; Petr Blasch; Diana Szilagyi; Alfonso Baldi; Paolo Persichetti; Anna Crescenzi; Michal Michal; Dmitry V Kazakov Journal: Mod Pathol Date: 2021-12-02 Impact factor: 7.842
Authors: Oriol Yélamos; Cristián Navarrete-Dechent; Michael A Marchetti; Tova Rogers; Zoe Apalla; Philippe Bahadoran; Nuria Blázquez-Sánchez; Klaus Busam; Cristina Carrera; Stephen W Dusza; Arnaud de la Fouchardière; Gerardo Ferrara; Pedram Gerami; Harald Kittler; Aimilios Lallas; Josep Malvehy; José F Millán-Cayetano; Kelly C Nelson; Victor Li Quan; Susana Puig; Howard Stevens; Luc Thomas; Ashfaq A Marghoob Journal: J Am Acad Dermatol Date: 2018-09-20 Impact factor: 11.527
Authors: Neil Farquhar; Sophie Thornton; Sarah E Coupland; Judy M Coulson; Joseph J Sacco; Yamini Krishna; Heinrich Heimann; Azzam Taktak; Colleen M Cebulla; Mohamed H Abdel-Rahman; Helen Kalirai Journal: J Pathol Clin Res Date: 2017-11-13